WAT Medical Sponsors American Headache Society 2024 Scottsdale Headache Symposium

December 10, 2024 01:00 AM AEDT | By Cision

Google News:

WAT Medical Sponsors American Headache Society 2024 Scottsdale Headache Symposium — Image source: Kalkine Media

Recent News

James Hardie Achieves FY25 Guidance Issues FY26 Guidance for Organic S...

US oil futures ease after API reports surprise increase in domestic cr...

AI Mode takes center stage at I/O 2025 as Google seeks to reinvent sea...

Pro Bono Institute Recognizes Marcus Brown With 2025 Laurie D. Zelon P...

VANCOUVER, BC, Dec. 9, 2024 /PRNewswire/ -- WAT Medical Enterprise proudly sponsored the 2024 Scottsdale Headache Symposium, organized by the American Headache Society from November 14-17 in Scottsdale, AZ. This annual event brought together a multidisciplinary audience of neurologists, general practitioners, pediatricians, anesthesiologists, psychologists, and other healthcare providers. The symposium featured diverse educational formats, including lectures, case studies, panel discussions, and hands-on demonstrations, offering cutting-edge insights into headache diagnosis and treatment.

One of the highlights of the event was the HeadaTerm 2, a newly developed neuromodulation device that garnered significant attention for its innovative design, ease of use, and competitive pricing. HeadaTerm 2 utilizes external trigeminal nerve stimulation and is FDA-cleared for the preventive treatment of migraines. Clinical studies indicate that it can be up to 35% more effective than oral NSAIDs in managing acute migraine episodes, underscoring its potential to transform headache care.

Additionally, WAT Medical showcased EmeTerm, an FDA-cleared anti-nausea wristband designed to alleviate nausea and vomiting often associated with migraines. The drug-free wristband, highly rated by consumers and clinicians, is a top-selling product on Amazon and widely endorsed by medical professionals across North America.

By collaborating with influential organizations such as the American Headache Society and the American Migraine Foundation, WAT Medical continues its commitment to advancing migraine treatment through groundbreaking neuromodulation technologies, aiming to enhance patient outcomes and improve quality of life.

References:

[1]Hokenek N M, Erdogan M O, Hokenek U D, et al. Treatment of migraine attacks by transcutaneous electrical nerve stimulation in emergency department: A randomize controlled trial[J]. The American Journal of Emergency Medicine, 2021, 39: 80-85.
[2]www.americanheadachesociety.org
[3]www.watmedical.com
[4]www.emeterm.com

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.